secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2024-12-05T23:59:59+00:00
Accession:  0001193125-24-270867
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health issues $3B junior subordinated notes: 7.0% due 2055, 6.75% due 2054
------------------------------------------------------------------------------

- Issued $2.25B of 7.000% Series A Junior Subordinated Notes due 2055 and $750M of 6.750% Series B Junior Subordinated Notes due 2054.
- Expected net proceeds ~$2.963B after underwriting discounts and expenses.
- Closing expected December 10, 2024; lead underwriters include Barclays, Citigroup, Goldman Sachs.
- Registration statement on Form S-3ASR (File No. 333-272200) effective May 25, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000119312524270867/0001193125-24-270867-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000119312524270867/d910747d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-270867

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer